Sanofi

Sanofi headquarters Sanofi

Biotech

Sanofi returns to TCEs via $1.2B pact for ph.1-stage trispecific

Sanofi has returned to TCE territory via an agreement to pay $180 million in the near term for a phase 1-stage trispecific from Kali Therapeutics.

James Waldron Mar 23, 2026 9:27am

target reach ladder climb meet win beat competition

Apogee data drive hype as threat to Lilly, Sanofi becomes clear

Mar 23, 2026 9:00am

dollar sign pipeline

Teva's $400M Blackstone deal to fund Sanofi-partnered IBD drug

Mar 4, 2026 3:07am

Sanofi

Fierce Pharma

Sanofi inks $1.5B deal for Sino Biopharm's novel asset

Mar 4, 2026 3:00am

Yellow Paraglider Flying Over the Peaks of the French Alps

Roche taps Aussie oncologist to lead research—Chutes & Ladders

Feb 20, 2026 8:30am

Brett Giroir

Sanofi backs Altesa's $75M series B to bankroll rhinovirus study

Feb 19, 2026 7:00am